The Journal of thoracic and cardiovascular surgery
-
J. Thorac. Cardiovasc. Surg. · Mar 2013
Contemporary open aortic arch repair with selective cerebral perfusion in the era of endovascular aortic repair.
With the recent advance of endovascular aortic repair, conventional open repair for aortic arch lesions should be reassessed. We reviewed our contemporary open arch repair with selective antegrade cerebral perfusion by way of the axillary artery with deep or moderate hypothermia. ⋯ Conventional open arch repair yielded satisfactory outcomes and should remain the standard therapy, with good long-term durability in all but high-risk patients.
-
J. Thorac. Cardiovasc. Surg. · Mar 2013
Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer.
To clarify the perioperative and oncologic outcome of pulmonary resection for a metachronous second primary lung cancer (MSPLC) following resection of an initial non-small cell lung cancer (NSCLC). ⋯ Surgical treatment of a MSPLC can be undertaken with 5-year survival rate of 60%. Expected operative morbidity and mortality are comparable to primary surgery. Tumors 2 cm or smaller are associated with improved survival and freedom from recurrence. Close long-term follow-up of patients who have undergone resection of NSCLC is recommended.
-
J. Thorac. Cardiovasc. Surg. · Mar 2013
Treatment of aortic arch aneurysms with a modular transfemoral multibranched stent-graft: initial experience.
To present an initial experience with a new modular transfemoral multibranched stent-graft for treating aortic arch aneurysms. ⋯ We have demonstrated the technical feasibility of a modular transfemoral branched stent-graft for treatment of aortic arch aneurysms. Our initial experience has shown that the method is relatively safe. Long-term follow-up is necessary to evaluate the efficacy and safety of this new device.